Angiopoietin‐like protein 1 antagonizes MET receptor activity to repress sorafenib resistance and cancer stemness in hepatocellular carcinoma - Chen, Hsin‐An; Kuo, Tsang‐Chih; Tseng, Chi‐Feng; Ma, Jui‐Ti; Yang, Shu‐Ting; Yen, Chia‐Jui; Yang, Ching‐Yao; Sung, Shian‐Ying; Su, Jen‐Liang (Hepatology (Baltimore, Md.), 2016)
Keywords: AKT protein; Angiogenesis; Angiopoietin; Angiopoietin-like Proteins; Angiopoietins - physiology; Animals; Antineoplastic Agents - therapeutic use; Carcinoma, Hepatocellular - drug therapy; Drug Resistance, Neoplasm; EGR-1 protein; Extracellular signal-regulated kinase; Female; Hepatocellular carcinoma; Hepatology; Humans; Inhibitor drugs; Kinases; Liver cancer; Liver Neoplasms - drug therapy; Male; Mesenchyme; Metastases; Mice; Middle Aged; Neoplastic Stem Cells; Niacinamide - analogs & derivatives; Niacinamide - therapeutic use; Phenylurea Compounds - therapeutic use; Proteins; Proto-Oncogene Proteins c-met - physiology; Stem cells; Targeted cancer therapy; Tumor suppressor genes